Case 27-2013: A 6.5-month-old boy with fever, rash, and cytopenias

New England Journal of Medicine

Volumn 369, Issue 9, 2013, Pages 853-863

  Iyengar, Shuba R ^a,b   Ebb, David H ^a,b   Yuan, Qian ^a,b   Shailam, Randheer ^a,b   Bhan, Atul K ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CEFIXIME; CEFTRIAXONE; IBUPROFEN; IMMUNOGLOBULIN; INFUSION FLUID; PARACETAMOL; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BLOOD CULTURE; CASE REPORT; CD3+ T LYMPHOCYTE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FACE DISORDER; FEVER; HEMOLYTIC ANEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; LEG DISEASE; LETHARGY; MALE; PETECHIA; PRIORITY JOURNAL; RASH; THORAX DISEASE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VOMITING; BLOOD; BLOOD EXAMINATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FLOW CYTOMETRY; LYMPHOCYTE COUNT;

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; EXANTHEMA; FEVER; FLOW CYTOMETRY; HEMATOLOGIC TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LYMPHOCYTE COUNT; MALE; MYCOPHENOLIC ACID; THROMBOCYTOPENIA;

EID: 84883083984     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1209277     Document Type: Article

References (20)

1. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003;112:973-80. (Pubitemid 37412068)
2. Kühne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143:605-8. (Pubitemid 37452786)
3. Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am 2010;24:249-73.
4. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884-93.
5. D'Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol 2013;35:1-13.
6. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190-207.
7. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-86.
8. Yong PL, Orange JS, Sullivan KE. Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol 2010;21:852-8.
9. Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood 2010;115:2142-5.
10. Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance. Autoimmun Rev 2010;9:488-93.
11. Bristeau-Leprince A, Mateo V, Lim A, et al. Human TCR alpha/beta+ CD4-CD8-double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells. J Immunol 2008;181:440-8.
12. Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010;116(14):e35-e40.
13. Bleesing JJ, Brown MR, Dale JK, et al. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol 2001;100:314-24.
14. Bleesing JJ, Morrow MR, Uzel G, Fleisher TA. Human T cell activation induces the expression of a novel CD45 isoform that is analogous to murine B220 and is associated with altered O-glycan synthesis and onset of apoptosis. Cell Immunol 2001;213:72-81. (Pubitemid 34074972)
15. Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 1998;153:1541-50. (Pubitemid 28509911)
16. Magerus-Chatinet A, Neven B, Stolzenberg MC, et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 2011;121:106-12.
17. Bowen RA, Dowdell KC, Dale JK, et al. Elevated vitamin B12 levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes. Clin Biochem 2012;45:490-2.
18. Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 2009;113:3027-30.
19. Ohga S, Nomura A, Takahata Y, et al. Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-) alphabetaT cells of autoimmune lymphoproliferative syndrome. Br J Haematol 2002;119:535-8. (Pubitemid 35365510)
20. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001;98:194-200.